Drugmakers pin hopes on new private research body

The new private consultative body, which has been sought by the Korea Drug Research Association (KDRA) in May, has drawn keen interest from the industry as the body will play a pivotal role to spur the long-term growth of research and development (R&D) oriented companies .

KDRA officials said that the consultative body will reinforce open innovation and partnership strategy through decentral...